Shortened telomeres in the expanded CD28- CD8+ cell subset in HIV disease implicate replicative senescence in HIV pathogenesis

AIDS

Volumn 10, Issue 8, 1996, Pages

  Effros, Rita B ^a,c   Allsopp, Richard ^b   Chiu, Choy Pik ^c   Hausner, Mary Ann ^a   Hirji, Kar Im ^a   Wang, Lili ^c   Harley, Calvin B ^a   Villeponteau, Bryant ^b   West, Michael D ^a   Giorgi, Janis V ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b ROSS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c GERON CORPORATION   (United States)

Author keywords

CD28; CD8; Immune exhaustion; Lymphocyte turnover; Replicative senescence; Telomeres

Indexed keywords

CD28 ANTIGEN; CD8 ANTIGEN;

ARTICLE; CELL AGING; CELL DIVISION; CLINICAL ARTICLE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MONONUCLEAR CELL; PRIORITY JOURNAL; SENESCENCE; SOUTHERN BLOTTING; T LYMPHOCYTE SUBPOPULATION; TELOMERE; VIRUS PATHOGENESIS; VIRUS REPLICATION;

EID: 8944258925     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002030-199607000-00001     Document Type: Article

References (39)

1. Greider CW: Mammalian telomere dynamics: healing, fragmentation shortening and stabilization. Curr Opin Genet Dev 1994, 4:203-211.
2. Campisi J, Dimri G, Hara E: Control of replicalive senescence. In Handbook of the Biology of Aging. Edited by Schneider EL, Rovve JW San Diego: Academic Press; 1996:121-149.
3. Vaziri H, Schächter F, Uchida I, et al.: Loss of telomeric DNA during aging of normal and trisomy 21 human lymphocytes. Am I Hum Genet 1993, 52:661-667.
4. Perillo NL, Walford RL, Newman MA, Effros RB: Human T lymphocytes possess a limited in vitro life span. Fxp Cemntol 1989, 24:177-187.
5. Effros RB, Boucher N, PorterV, et al.: Decline in CD28+T cells in centenarians and in long-term T cell cultures: a possible cause for both in vivo and in vitro immunosenescence. fxp Gerontol 1994,29:601-609.
6. Pantaleo G, Koenig S, Baseler M, Lane HC, Fauci AS: Defective clonogenic potential of CD8+ T lymphocytes in patients with AIDS: expansion in vivo of a nonclonogenic CD3+CD8+DR+ CD25 - T cell population. 1 Immunol 1990,144:1696-1704.
7. Ferbas J, Kaplan AH, Hausner MA, et al.: Viral burden in HIVinfected long-term survivors is a determinant of anti-HIV CD8+ lymphocyte activity. J Infect Dis 1995,172:329-339.
8. Giorgi JV, Ho H-N, Hirji K, etal.: CD8+ lymphocyte activation at human immunodeficiency virus type 1 seroconversion: development of HLA-DR+CD38-CD8+ cells is associated with subsequent stable CD4+ cell levels. J Infect Dis 1994,170:775-781.
9. Ho H-N, Hultin LE, Mitsuyasu RT, et al.: Circulating HIV-specific CD8+ cytotoxic T cells express CD38 and HLA-DR antigens. J Immunol 1993,150:3070-3079.
10. Rantaleo C, Demarest JF, Soudeyns H, et al.: Major expansion of CDS-1- T cells with a predominant Vß usage during the primary immune response to HIV. Nature 1994, 370:463-467.
11. Lewis DE, Tang DSN, Adu-Oppong A, Schober W, Rodgers JR: Anergy and apoptosis in CD8+ T cells from HIV-infected persons. J Immunol 1994, 153:412-420.
12. Brinchmann JE, DoblougJH, Heger BH, Haaheim LL, Sannes M, Egeland T: Expression of costimulatory molecule CD28 on T cells in human immunodeficiency virus type 1 infection: functional and clinical correlations. J Infect Dis 1994, 169:730-738.
13. Borthwick NJ, Bofill M, Gombert WM, et al.: Lymphocyte activation in HIV-1 infection. II. Functional defects of CD28- T cells. AIDS 1994, 8:431-441.
14. Jennings C, Rich K, Siegel JN, Landay A: A phenotypic study of CD8+ lymphocyte subsets in infants using three-color flow cytometry. Clin Immunol Immunopathol 1994, 71:8-13.
15. Giorgi JV, Boumsell L, Autran B: Reactivity of workshop T-cell section mAb with circulating CD4+ and CD8+T cells in HIV disease and following in vitro activation. In Leucocyte Typing V: White Cell Differentiation Antigens. Edited by Schlossman SF, Boumsell L, Gilks W, et al. Oxford: Oxford University Press; 1995:446-461.
16. Kaslow RA, Ostrovv DC, Detels R, Phair JP, Polk BF, Rinaldo CR: The Multicenter AIDS Cohort Study: rationale, organization, and selected characteristics of the participants. Am J Epidemiol 1987, 126:310-318.
17. Saukkonen JJ, Kornfeld H, Berman JS: Expansion of a CD8+CD28- cell population in the blood and lung of HIVpositive patients. J Acquir Immune Deftc Syndr 1993, 6:11941204.
18. Mueller DL, Jenkins MK, Schwartz RH: Clonal expansion versus functional clonal inactivation: a costimulatory signalling pathway determines the outcome of T cell antigen receptor occupancy. Annu Rev Immunol 1989, 7:445-480.
19. Groux H, Torpier G, Monté D, Mouton Y, Capron A, Ameisen JC: Activation-induced death by apoptosis in CD4+ T cells from human immunodeficiency virus-infected asymptomatic individuals. I Exp Med 1992, 175:331-340.
20. Meyaard L, Otto SA, Jonker RR, Mijnster MJ, Keet RP, Miedema F: Programmed death of T cells in HIV-1 infection. Science 1992, 257:217-219.
21. Gougeon M-L, Garcia S, Heeney J, ef aJ.: Programmed cell death in AIDS-related H1V and SIV infections. AIDS Res Hum Retroviruses 1993, 9:553-563.
22. Kirn NW, Piatyszek MA, Prowse KR, etal.: Specific association of human telomerase activity with immortal cells and cancer. Science 1994, 266:2011-2015.
23. Allsopp RC, Vaziri H, Patterson C, ef at.: Telomere length predicts replicative capacity of human fibroblasts. Proc Natl Acad Sei USA 1992, 89:10114-10118.
24. Moskophidis D, Lechner F, Pircher H, Zinkernagel RM: Virus persistence in acutely infected immunocompetent mice by exhaus-tion of antiviral cytotoxic effectorT cells. Nature 1993,362:758761.
25. Dimri GP, Lee X, Basile G, et al.: A novel biomarker identifies senescent human cells in culture and in aging skin in vivo. Proc NatlAcadSci USA 1995, 92:9363-9367.
26. Chang E, Harley CB: Telomere length and replicalive aging in human vascular tissues. Proc Natl Acad Sei USA 1995, 92:11190-11194.
27. Giorgi JV, Liu Z, Hultin LE, Cumberland WG, Hennessey K, Detels R: Elevated levels of CD38+CD8+T cells in HIV infection add to the prognostic value of low CD4+T cell levels: results of 6 years of follow-up. J Acquir Immune Defic Syndr 1993, 6:904912.
28. Liu Z, Hultin LE, Cumberland WG, et al.: Elevated relative fluorescence intensity of CD38 antigen expression on CD8+ T cells is a marker of poor prognosis in HIV infection: results of 6 years of follow-up. Commun Clin Cytometty 1996, 26:1-7.
29. Damle NK, Mohagheghpour N, Hansen JA, Engleman EG: Alloantigen-specific cytotoxic and suppressor T lymphocytes are derived from phenotypically distinct precursors. J Immunol 1983, 131:2296-2300.
30. LandayA, GartlandGL, Clement LT: Characterization of a phenotypically distinct subpopulation of Leu-2 + cells that suppresses T cell proliferative responses. I Immunol 1983,131:2757-2761.
31. Landay AL, Mackewicz CE, Levy JA: An activated CD8+ T cell phenotype correlates with anti-HIV activity and asymptomatic clinical status. Clin Immunol Immunopathol 1993, 69:106-116.
32. Prince HE, Jensen ER: HIV-related alterations in CDS cell subsets defined by in vitro survival characteristics. Cell Immunol 1991, 134:276-286.
33. Wei X, Ghosh SK, Taylor ME, et al.: Viral dynamics in human immunodeficiency virus type 1 infection. Nature 1995, 373:117-122.
34. Ho DD, Neumann AU, Perelson AS, Chen W, Leonard JM, Markowitz M: Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection. Nature 1995, 373:123-126.
35. Carmichael A, Jin X, Sissons P, Borysiewicz L: Quantitative analysis of the human immunodeficiency virus type 1 (HlV-l)-specific cytotoxic T lymphocyte (CTL) response at different stages of HIV-1 infection: differential CTL responses to HIV-1 and Epstein-Barr virus in late disease. J Exp Med 1993,177:249-256.
36. Kalams SA, Johnson RP, Trotha AK, et al.: Longitudinal analysis of T cell receptor (TCR) gene usage by human immunodeficiency virus 1 envelope-specific cytotoxic T lymphocyte clones reveals a limited TCR repertoire. ; Exp Med 1994,179:1261-1271.
37. McMichael AJ, Walker BD: Cytotoxic T lymphocyte epitopes: implications for HIV vaccines. AIDS 1994, 8 (suppl 1):S155S173.
38. Doherty PC, Hou S, Tripp RA: CD8+ T cell memory to viruses. Curr Opin Immunol 1994, 6:545-552.
39. Hiyama K, Hirai Y, Kyoizumi S, et al.: Activation of telomerase in human lymphocytes and hematopoietic progenitor cells. J Immunol 1995,155:3711-3715.